Donald Kitt
Neurology · San Francisco, CANPI 1477641090
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations.
Across 127 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$332
- Neurocrine Biosciences, Inc.$319
- Amgen$215
- Boston Scientific$146
- Lundbeck LLC$134
- Sunovion Pharmaceuticals Inc.$117
- plus $830 from 17 others
What the payments were for
- Food & beverage$2,093100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 19 | $332 |
| Neurocrine Biosciences, Inc. | 44 | $319 |
| Amgen | 6 | $215 |
| Boston Scientific | 1 | $146 |
| Lundbeck LLC | 7 | $134 |
| Sunovion Pharmaceuticals Inc. | 7 | $117 |
| Kyowa Kirin, Inc. | 7 | $114 |
| Teva Pharmaceuticals USA, Inc. | 5 | $96 |
| Novartis | 5 | $90 |
| AbbVie | 3 | $68 |
| Biogen | 3 | $63 |
| UCB, Inc. | 3 | $59 |
| Avanir Pharmaceuticals, Inc. | 3 | $56 |
| Arbor Pharmaceuticals, Inc. | 3 | $55 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| AstraZeneca | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| MDD US Operations, LLC | 1 | $21 |
| Almatica Pharma LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL DBS$146
- AIMOVIG$101
How this compares
$2,093 in reported general payments places this provider in the 55th percentile of 1,996 neurology providers in California.
Other neurology in San Francisco
- S Claiborne JohnstonSan Francisco$576K
- Armen MoughamianSan Francisco$554K
- Scott ZamvilSan Francisco$447K
- Bruce CreeSan Francisco$412K
- Kenneth LaxerSan Francisco$379K
- Jonathan KatzSan Francisco$294K
- Nada HindiyehSan Francisco$268K
- Douglas GoodinSan Francisco$227K
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.